nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiangiogenic therapy: Markers of response, “normalization” and resistance
|
El Alaoui-Lasmaili, Karima |
|
2018 |
128 |
C |
p. 118-129 |
artikel |
2 |
A revisited concept. Tumors: Wounds that do not heal
|
Ribatti, Domenico |
|
2018 |
128 |
C |
p. 65-69 |
artikel |
3 |
Corrigendum to “Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review” [Crit. Rev. Oncol./Hematol. 124, April (2018), 61–65]
|
Kam, Tsz Yeung |
|
2018 |
128 |
C |
p. 139 |
artikel |
4 |
Editorial Board
|
|
|
2018 |
128 |
C |
p. IFC |
artikel |
5 |
Glutathione system in animal model of solid tumors: From regulation to therapeutic target
|
Corso, Claudia Rita |
|
2018 |
128 |
C |
p. 43-57 |
artikel |
6 |
Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy
|
Zhao, Bin |
|
2018 |
128 |
C |
p. 110-117 |
artikel |
7 |
Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation
|
Mohammadi, Asadollah |
|
2018 |
128 |
C |
p. 1-18 |
artikel |
8 |
Molecular targets of celastrol in cancer: Recent trends and advancements
|
Kashyap, Dharambir |
|
2018 |
128 |
C |
p. 70-81 |
artikel |
9 |
Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis
|
Gregg, Richard W. |
|
2018 |
128 |
C |
p. 58-64 |
artikel |
10 |
Radiation therapy in renal cell carcinoma
|
De Felice, Francesca |
|
2018 |
128 |
C |
p. 82-87 |
artikel |
11 |
Tafro syndrome: Critical review for clinicians and pathologists
|
Paydas, Semra |
|
2018 |
128 |
C |
p. 88-95 |
artikel |
12 |
Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma
|
Elmaci, Ilhan |
|
2018 |
128 |
C |
p. 96-109 |
artikel |
13 |
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
|
Frega, Stefano |
|
2018 |
128 |
C |
p. 19-29 |
artikel |
14 |
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
|
Di Tucci, Chiara |
|
2018 |
128 |
C |
p. 30-42 |
artikel |
15 |
When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
|
Gori, Stefania |
|
2018 |
128 |
C |
p. 130-138 |
artikel |